In:
Alzheimer's & Dementia, Wiley, Vol. 12, No. 6 ( 2016-06), p. 645-653
Abstract:
Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer's disease. The Alzheimer's disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state‐of‐the‐art in predicting cognitive outcomes in Alzheimer's disease based on high dimensional, publicly available genetic and structural imaging data. This meta‐analysis failed to identify a meaningful predictor developed from either data modality, suggesting that alternate approaches should be considered for prediction of cognitive performance.
Type of Medium:
Online Resource
ISSN:
1552-5260
,
1552-5279
DOI:
10.1016/j.jalz.2016.02.006
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
2201940-6
Bookmarklink